These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 10556873)

  • 1. Re-learning in Alzheimer's disease.
    Winter J; Hunkin NM
    Int J Geriatr Psychiatry; 1999 Nov; 14(11):988-90. PubMed ID: 10556873
    [No Abstract]   [Full Text] [Related]  

  • 2. Recall and recognition of verbal paired associates in early Alzheimer's disease.
    Lowndes GJ; Saling MM; Ames D; Chiu E; Gonzalez LM; Savage GR
    J Int Neuropsychol Soc; 2008 Jul; 14(4):591-600. PubMed ID: 18577288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients with Alzheimer's disease use metamemory to attenuate the Jacoby-Whitehouse illusion.
    Willems S; Germain S; Salmon E; Van der Linden M
    Neuropsychologia; 2009 Oct; 47(12):2672-6. PubMed ID: 19467250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associative recognition in Alzheimer's disease: evidence for impaired recall-to-reject.
    Gallo DA; Sullivan AL; Daffner KR; Schacter DL; Budson AE
    Neuropsychology; 2004 Jul; 18(3):556-63. PubMed ID: 15291733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired production priming and intact identification priming in Alzheimer's disease.
    Fleischman DA; Monti LA; Dwornik LM; Moro TT; Bennett DA; Gabrieli JD
    J Int Neuropsychol Soc; 2001 Nov; 7(7):785-94. PubMed ID: 11771621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non pharmacological treatment in Alzheimer's disease.
    Bianchetti A; Zanetti O; Trabucchi M
    Funct Neurol; 1997; 12(3-4):215-7. PubMed ID: 9218982
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of the memory performances of young and old subjects with those of Alzheimer's disease patients: support for a discontinuity between natural and pathological aging.
    Caltagirone C
    Funct Neurol; 1997; 12(3-4):213. PubMed ID: 9218981
    [No Abstract]   [Full Text] [Related]  

  • 8. Early detection of Alzheimer's disease (AD) using the CANTAB paired Associates Learning Test.
    O'Connell H; Coen R; Kidd N; Warsi M; Chin AV; Lawlor BA
    Int J Geriatr Psychiatry; 2004 Dec; 19(12):1207-8. PubMed ID: 15578796
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment for Alzheimer's disease.
    Wilcock GK
    Int J Geriatr Psychiatry; 2000 Jun; 15(6):562-5. PubMed ID: 10861924
    [No Abstract]   [Full Text] [Related]  

  • 10. Rey verbal learning test is a useful tool for differential diagnosis in the preclinical phase of Alzheimer's disease: comparison with mild cognitive impairment and normal aging.
    Estévez-González A; Kulisevsky J; Boltes A; Otermín P; García-Sánchez C
    Int J Geriatr Psychiatry; 2003 Nov; 18(11):1021-8. PubMed ID: 14618554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Confabulations in episodic memory are associated with delusions in Alzheimer's disease.
    Lee E; Meguro K; Hashimoto R; Meguro M; Ishii H; Yamaguchi S; Mori E
    J Geriatr Psychiatry Neurol; 2007 Mar; 20(1):34-40. PubMed ID: 17341769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of neuropsychological tests in the Cronos Project].
    Bianchi G; Gasparini M; Caffari B; Sorrentino GC; Bianchi C; Bruno G; Maggini M; Raschetti R; Vanacore N
    Ann Ist Super Sanita; 2005; 41(1):69-74. PubMed ID: 16037653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of distinctive features and a broader pattern of priming in Alzheimer's disease.
    Alathari L; Trinh Ngo C; Dopkins S
    Neuropsychology; 2004 Oct; 18(4):603-12. PubMed ID: 15506827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effect of cholinesterase inhibitor medications on recognition memory performance in mild to moderate Alzheimer's disease: preliminary findings.
    Crowell TA; Paramadevan J; Abdullah L; Mullan M
    J Geriatr Psychiatry Neurol; 2006 Mar; 19(1):13-5. PubMed ID: 16449754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A neuropsychological test battery for use in Alzheimer disease clinical trials.
    Harrison J; Minassian SL; Jenkins L; Black RS; Koller M; Grundman M
    Arch Neurol; 2007 Sep; 64(9):1323-9. PubMed ID: 17846273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for amnestic mild cognitive impairment and early Alzheimer's disease with M@T (Memory Alteration Test) in the primary care population.
    Rami L; Molinuevo JL; Sanchez-Valle R; Bosch B; Villar A
    Int J Geriatr Psychiatry; 2007 Apr; 22(4):294-304. PubMed ID: 16998781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective screening for Alzheimer's disease in everyday practice.
    Lee SS
    JAAPA; 2001 Jul; 14(7):39-48. PubMed ID: 11517820
    [No Abstract]   [Full Text] [Related]  

  • 18. Verbal learning in Alzheimer's dementia.
    Au A; Chan AS; Chiu H
    J Int Neuropsychol Soc; 2003 Mar; 9(3):363-75. PubMed ID: 12666761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation between mild cognitive impairment, Alzheimer's disease and depression by means of cued recall.
    Dierckx E; Engelborghs S; De Raedt R; De Deyn PP; Ponjaert-Kristoffersen I
    Psychol Med; 2007 May; 37(5):747-55. PubMed ID: 17164030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frontotemporal dementia, semantic dementia, and Alzheimer's disease: the contribution of standard neuropsychological tests to differential diagnosis.
    Diehl J; Monsch AU; Aebi C; Wagenpfeil S; Krapp S; Grimmer T; Seeley W; Förstl H; Kurz A
    J Geriatr Psychiatry Neurol; 2005 Mar; 18(1):39-44. PubMed ID: 15681627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.